Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 1906 AL 1920

Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study

Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, Sekita A, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T.

Neurology. 2010 Aug 31;75(9):764-70. doi: 10.1212/WNL.0b013e3181eee25f. Epub 2010 Aug 25.

Change in risk of Alzheimer disease over time

Hebert LE, Bienias JL, Aggarwal NT, Wilson RS, Bennett DA, Shah RC, Evans DA.

Neurology. 2010 Aug 31;75(9):786-91. doi: 10.1212/WNL.0b013e3181f0754f.

Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesia

Vanderweyde T, Bednar MM, Forman SA, Wolozin B.

J Alzheimers Dis. 2010;22 Suppl 3(Suppl 3):91-104. doi: 10.3233/JAD-2010-100843.

Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?

Thoonsen H, Richard E, Bentham P, Gray R, van Geloven N, De Haan RJ, Van Gool WA, Nederkoorn PJ.

Stroke. 2010 Nov;41(11):2690-2. doi: 10.1161/STROKEAHA.109.576975. Epub 2010 Oct 7.

New developments in the diagnosis of dementia

Eschweiler GW, Leyhe T, Klöppel S, Hüll M.

Dtsch Arztebl Int. 2010 Oct;107(39):677-83. doi: 10.3238/arztebl.2010.0677. Epub 2010 Oct 1.

Predicting cognitive decline in Alzheimer's disease: an integrated analysis

Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson D, Waldemar G, Zhang R, Schindler R.

Alzheimers Dement. 2010 Nov;6(6):431-9. doi: 10.1016/j.jalz.2010.04.003.

Genetics of Alzheimer disease

Bekris LM, Yu CE, Bird TD, Tsuang DW.

J Geriatr Psychiatry Neurol. 2010 Dec;23(4):213-27. doi: 10.1177/0891988710383571.

Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988-2007

Baker NL, Cook MN, Arrighi HM, Bullock R.

Age Ageing. 2011 Jan;40(1):49-54. doi: 10.1093/ageing/afq146. Epub 2010 Nov 18.

Preventing Alzheimer's disease and cognitive decline

Williams JW, Plassman BL, Burke J, Benjamin S.

Evid Rep Technol Assess (Full Rep). 2010 Apr;(193):1-727.

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease

Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K.

Int J Geriatr Psychiatry. 2011 Sep;26(9):937-43. doi: 10.1002/gps.2630. Epub 2010 Dec 28.

Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease

Fiala M, Veerhuis R.

Exp Gerontol. 2010 Jan;45(1):57-63. doi: 10.1016/j.exger.2009.08.003. Epub 2009 Aug 21.

Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications

Ho L, Fivecoat H, Wang J, Pasinetti GM.

Exp Gerontol. 2010 Jan;45(1):15-22. doi: 10.1016/j.exger.2009.09.007. Epub 2009 Sep 29.

Sleep and biomarkers of atherosclerosis in elderly Alzheimer caregivers and controls

von Känel R, Ancoli-Israel S, Dimsdale JE, Mills PJ, Mausbach BT, Ziegler MG, Patterson TL, Grant I.

Gerontology. 2010;56(1):41-50. doi: 10.1159/000264654. Epub 2009 Dec 3.

Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men

Chu LW, Tam S, Wong RL, Yik PY, Song Y, Cheung BM, Morley JE, Lam KS.

J Alzheimers Dis. 2010;21(4):1335-45. doi: 10.3233/jad-2010-100027.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias